Your browser doesn't support javascript.
loading
Post-translational control of beige fat biogenesis by PRDM16 stabilization.
Wang, Qiang; Li, Huixia; Tajima, Kazuki; Verkerke, Anthony R P; Taxin, Zachary H; Hou, Zhishuai; Cole, Joanne B; Li, Fei; Wong, Jake; Abe, Ichitaro; Pradhan, Rachana N; Yamamuro, Tadashi; Yoneshiro, Takeshi; Hirschhorn, Joel N; Kajimura, Shingo.
Afiliação
  • Wang Q; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Li H; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Tajima K; Department of Endocrinology and Metabolism, National Hospital Organization, Yokohama Medical Center, Yokohama, Japan.
  • Verkerke ARP; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Taxin ZH; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Hou Z; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Cole JB; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Li F; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Wong J; Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
  • Abe I; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Pradhan RN; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Yamamuro T; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Yoneshiro T; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Hirschhorn JN; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Kajimura S; Oncology Bioinformatics, Genentech, San Francisco, CA, USA.
Nature ; 609(7925): 151-158, 2022 09.
Article em En | MEDLINE | ID: mdl-35978186
Compelling evidence shows that brown and beige adipose tissue are protective against metabolic diseases1,2. PR domain-containing 16 (PRDM16) is a dominant activator of the biogenesis of beige adipocytes by forming a complex with transcriptional and epigenetic factors and is therefore an attractive target for improving metabolic health3-8. However, a lack of knowledge surrounding the regulation of PRDM16 protein expression hampered us from selectively targeting this transcriptional pathway. Here we identify CUL2-APPBP2 as the ubiquitin E3 ligase that determines PRDM16 protein stability by catalysing its polyubiquitination. Inhibition of CUL2-APPBP2 sufficiently extended the half-life of PRDM16 protein and promoted beige adipocyte biogenesis. By contrast, elevated CUL2-APPBP2 expression was found in aged adipose tissues and repressed adipocyte thermogenesis by degrading PRDM16 protein. Importantly, extended PRDM16 protein stability by adipocyte-specific deletion of CUL2-APPBP2 counteracted diet-induced obesity, glucose intolerance, insulin resistance and dyslipidaemia in mice. These results offer a cell-autonomous route to selectively activate the PRDM16 pathway in adipose tissues.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas de Ligação a DNA / Tecido Adiposo Bege Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas de Ligação a DNA / Tecido Adiposo Bege Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article